Medical and Medication Errors CE Program. Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

Size: px
Start display at page:

Download "Medical and Medication Errors CE Program. Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital"

Transcription

1 Medical and Medication Errors CE Program Tom Johns, PharmD, BCPS Director, Pharmacy Services UF Health Shands Hospital

2 2

3 3

4 4

5 RANK ORDER OF ERROR REDUCTION STRATEGIES Forcing functions and constraints Automation, computerization, bar code scanning Standardization and protocols Time out, checklists and double check systems Rules and policies Visual warnings (auxiliary labels) Education/information Be more careful, be vigilant 5

6 6

7 The Power of the Story Stories. attract attention promote critical thinking are memorable create empathy inspire and incite change ISMP Medication Safety Alert! September 8,

8 Heparin Clarian Health System 1 ml heparin vials that contained 10,000 units/ml misplaced into NICU unit-based automated dispensing cabinets by pharmacy technician 3 fatalities 8

9 9

10 10

11 11

12 Progesterone vaginal suppository Prostin E-2 vaginal suppository (prostanglandin E-2, dinoprostone) 12

13 13

14 14

15 15

16 Who do you blame for the error? Person approach Blames the individual person Bad things happen to bad people Focuses on unsafe acts Forgetfulness Poor motivation Negligence System approach Humans are fallible and errors are to be expected Focus on defenses, barriers and safeguards Errors are viewed as consequences of upstream systemic factors 16

17 17

18 Were the actions as intended? Unauthorized substance? Knowingly violate safe operating procedures? No No No Pass substitution test? Yes History of unsafe acts? Yes No Yes Yes No Were the consequences as intended? Medical condition? Were procedures available, workable, intelligible and correct? Deficiencies in training & selection or inexperience? Yes No Yes Sabotage, malevolent damage, suicide, etc. No Substance abuse without mitigation Yes Substance abuse with mitigation Yes Possible reckless violation No Systeminduced violation Diminishing culpability No Possible negligent error Yes Systeminduced error Blameless error but corrective training, counseling needed Blameless error Decision Tree for Determining Culpability of Unsafe Acts Reason, J., Managing the Risks of Organizational 18 Accidents

19 Medication Error Definition A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient, or consumer. 19

20 Stage of Errors 20

21 21

22 22

23 23

24 Error Types Wrong drug Wrong patient Wrong dose Wrong time Wrong route Overdose Underdose Lack of drug Unnecessary drug 24

25 Most Common Drugs 25

26 Errors Contributing Factors Communication Look alike/sound alike medications Distractions and interruptions Knowledge deficit Calculation errors IV infusion pump administration errors Confirmation bias 26

27 Quantifying Adverse Drug Events Voluntary Medication Error Reporting 27

28 Voluntary Error Reporting Under-reporting of errors o o Estimated only 10-20% of actual errors are reported Should not use as a quantitative measure Many reasons for under-reporting o o o o You don t know what you don t know Fear Liability Time Value: learn what type of problems are occurring in your hospital from a qualitative perspective Goal: voluntarily reported medication error rates should increase over time o Indicates a positive culture of safety, where employees are encouraged and feel free to report errors 28

29 Medication Error Reporting 29

30 IHI Trigger Tool for Measuring Adverse Drug Events (ADEs) Using triggers to identify ADEs is an effective method for measuring the overall level of harm from medications Conducted through retrospective chart review with a multidisciplinary team Reported as a quantitative rate o ADEs per 1,000 doses o Percent of admissions with an ADE 30

31 Trigger Examples Vitamin K INR >6 Flumazenil Naloxone Glucose <50 Rising serum creatinine Over-sedation, lethargy, falls Abrupt cessation of medication 31

32 Medication Error Severity Definitions 32

33 Electronic Reporting 33

34 Healthy Root Cause Analysis A Structured (Reactive) Response to Medication Errors Everyone needs to play well in sandbox together: no finger pointing, no accusations, no passing judgment Multidisciplinary team including individuals involved in the error Importance of medical staff involvement Structured (semi) process - what happened, why did it happen (causes/contributing factors); what can be done to prevent it from happening again 34

35 A Framework for a Root Cause Analysis and Action Plan In Response to a Sentinel Event 35

36 Medication Error Analysis 36

37 37

38 TRANSPARENCY 38

39 Sterile Product Observations Incorrect BUD applied to CSP prepared in LAFH SDV used on multiple patients MDV without expiration date MDV used beyond expiration date Assumption that vial stopper is sterile underneath protective cap Infusion bags used as multidose container for flushes Needles and syringes stored unwrapped Medication prep areas unclean and cluttered Pre-spiking IV bags Inappropriate syringe labeling (or no label) 39

40 40

41 Avoid Unsafe Abbreviations Do not use any of the following: U,u - IU - Q.D., QD, q.d., qd - Q.O.D., QOD, q.o.d, qod - Trailing zero (X.0 mg) - Lack of leading zero (.X mg) - MS - MSO4 - MgSO4 41

42 Remove Concentrated Electrolytes from Patient Care Areas Concentrated potassium chloride (KCL) USP nomenclature changes 42

43 Labeling Syringes and Bowls 43

44 Identify and review a list of lookalike/soundalike drugs and take action to prevent errors involving the interchange of these drugs 44

45 Avoid Look-alike Products 45

46 46

47 Oral unit dose syringe availability 47

48 Oral unit dose syringe availability 48

49 Medication Reconciliation 49

50 Home Medication Profile Form 50

51 Patient Safety Initiatives Standardization of care Insulin protocols Heparin protocols VTE prophylaxis protocol Evaluation of process improvements Are they being ordered appropriately? Are the orders being followed by nursing staff? 51

52 Shands UF Heparin Protocol 52

53 Shands UF Heparin Documentation Tool 53

54 54

55 Insulin Ranks as #1/#2 in medication errors both internally and with external benchmarks Most common error types Look alike/sound alike mistakes Storage in original boxes IV infusion pump administration errors Dosage miscalculation withdrawing from vials 55

56 BEFORE AFTER Vials prefilled syringes Product/Name diversification 56

57 Heparin Shands UF evaluation Med Safety Committee All heparin products pulled for comparison Prevention strategy Utilize 10 unit/ml syringe instead of vial ($250,000 annual increase in drug budget) 57

58 58

59 NMB Error Prevention Strageties Conduct a failure-mode and effects analysis (FMEA) Store separately from other medications Limit availability to the pharmacy and patient care areas that routinely care for mechanically ventilated patients All institutionally prepared syringes or infusion containers of should contain a clearly visible, brightly colored alert stating, Warning: Paralyzing Agent (Use Requires Mechanical Ventilatory Assistance). 59

60 60

61 Promethazine ISMP Medication Safety Alert! August 10, 2006 Extravasation leading to amputation has occurred Contraindicated in children less than 2 y/o Potential to cause fatal respiratory depression Ensure 50 mg/ml vial is not stocked Created comment that appears on label and MAR.. dilute in 10 ml and infuse over 10 minutes 61

62 62

63 63

64 Smart Infusion Pumps Multiple types of pumps with central brain Guard rail technology (hard/soft alerts) Drug library Library can change for different patient populations (eg, adult, pediatrics, critical care) wireless or manual change Track averted errors 64

65 65

66 Alaris Smart Pump Alerts November 2009 Guardrails CQI Reporter Drug or Fluid Alerts by Times the Limit Ranges Count of Frequency Times Intended Dose Count

67 Insulin example Patient receiving Insulin infusion for tight blood glucose control in ICU Insulin infusion bag concentration is 0.5units/mL Intended rate was 2.4mL/hr Nurse programs the pump to run at 204mL/hr the Smartpump created a hard stop requiring the nurse to reprogram the pump. This was a keypad error as the decimal point is next to the zero on the face of the pump. This was a potentially lethal error that was avoided. 67

68 Medication Errors Captured by Alaris Smart Pump Insulin (Adult ICU) Programmed dose: 40 units/hr (80 ml/hr) Intended dose: 4 units/hr (8 ml/hr) NORepinephrine (Adult ICU) Programmed dose: 1.2 mcg/kg/min (189 ml/hr) Intended dose: 0.12 mcg/kg/min (18.9 ml/hr) FUROSemide DRIP (PICU) Programmed dose: 2 mg/kg/hr (3.4 ml/hr) Intended dose: 0.2 mg/kg/hr (0.34 ml/hr) 68

69 24 Hour Chronogram Reprogram Alerts 10 fold or greater only All Patients 22:00 23:00 0: :00 2:00 21: :00 20: :00 19: :00 18:00 0 6:00 17:00 7:00 16:00 8:00 15:00 9:00 14:00 13:00 12:00 11:00 10:00 69

70 Emergency Carts 70

71 Emergency Medication Tray 71

72 Risk reduction strategies to prevent medication errors during codes. 72

73 What s wrong with this picture? 73

74 74

75 75

76 76

77 77

78 78

79 79

80 80

81 What s wrong with this picture? 81

82 82

83 83

84 84

85 85

86 86

87 What s wrong with this picture? 87

88 88

89 89

90 90

91 91

92 92

93 93

94 94

95 95

96 96

97 97

98 98

99 99

100 100

101 101

102 102

103 103

104 104

105 105

106 106

107 107

108 108

109 109

110 Questions? 110

ISMP Targeted Medication Safety Best Practices. Christina Michalek, BS, RPh, FASHP

ISMP Targeted Medication Safety Best Practices. Christina Michalek, BS, RPh, FASHP ISMP 2018-2019 Targeted Medication Safety Best Practices Christina Michalek, BS, RPh, FASHP Objectives At the completion of this activity, you will be able to: Describe the most and least implemented Best

More information

High-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP)

High-Alert Medications: A Look at the Safe Use of Narcotics. Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP) High-Alert Medications: A Look at the Safe Use of Narcotics Allen Vaida, BSc, PharmD Institute for Safe Medication Practices (ISMP) Risk Identification in Healthcare The detection of a potential or actual

More information

ISMP guidelines that support intravenous drug delivery system safety

ISMP guidelines that support intravenous drug delivery system safety ISMP guidelines that support intravenous drug delivery system safety Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon), FASHP Institute for Safe Medication Practices Sterile Compounding Errors and Patient

More information

Opioid Safety: The balance between pain, sleep and breathing. Presentation Objectives STEP 1: DEFINING THE PROBLEM

Opioid Safety: The balance between pain, sleep and breathing. Presentation Objectives STEP 1: DEFINING THE PROBLEM Opioid Safety: The balance between pain, sleep and breathing Richard Ensign, PharmD, BCPS Pharmacy Clinical Manager Intermountain Healthcare Richard.Ensign@imail.org (801) 442-3232 Presentation Objectives

More information

Checklist/Action Plan for the Management of High-Alert Medications

Checklist/Action Plan for the Management of High-Alert Medications ... Attachment 1.G Checklist/Action Plan for the Management of High-Alert Medications (adapted from High-Alert Medications: Safeguarding Against Errors by Michael Cohen and Charles Kilo, In: Medication

More information

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS

Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Error Reduction Strategies for High-Alert Medications Kelly Besco, Pharm.D., FISMP, CPPS Medication Safety Officer OhioHealth Pharmacy Services Conflict of Interest Disclosure Kelly Besco declares no conflicts

More information

Establishing Special and Common Cause Variation

Establishing Special and Common Cause Variation This presenter has nothing to disclose Establishing Special and Common Cause Variation Carol Haraden, PhD March 3, 2017 Framework for Clinical Excellence Patient Safety Psychological Safety Accountability

More information

ISMP QuarterlyActionAgenda

ISMP QuarterlyActionAgenda One of the most important ways to prevent medication errors is to learn about problems that have occurred in other organizations and to use that information to prevent similar problems at your practice

More information

High alert medicines

High alert medicines High alert medicines Dr Cristín Ryan, Royal College of Surgeons in Ireland Dr Ahmed Awaisu, College of Pharmacy, Qatar University Dr Bridget Javed, College of Pharmacy, Qatar University Dr Wessam El Kassem,

More information

ISMP 2017 Updates Best Practices for Hospital Pharmacists

ISMP 2017 Updates Best Practices for Hospital Pharmacists ISMP 2017 Updates Best Practices for Hospital Pharmacists Lamis R. Karaoui, PharmD, BCPS Clinical Associate Professor Director of Experiential Education Lebanese American University School of Pharmacy

More information

Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP

Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP Patient Harm with Opioids: Can We Truly Reduce the Risk? Ali-Reza Shah-Mohammadi, PharmD, MS, FISMP Clinical Pharmacy Specialist Medication Safety Pharmacy Medication Management & Analytics The University

More information

Objectives. Key Elements. ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution 3/24/2014

Objectives. Key Elements. ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution 3/24/2014 ICAHN Targeted Focus Area: Drug Information and Drug Standardization and Distribution Matthew Fricker, RPh, MS, FASHP Program Director, ISMP Rebecca Lamis, PharmD, FISMP Medication Safety Analyst, ISMP

More information

Medication Calculation Practice Problems

Medication Calculation Practice Problems Medication Calculation Practice Problems Below is a section of the list of medications that are programmed in the Alaris IV Pump s Guardrail Drug Library. During your orientation you will learn more about

More information

Integrated Analytics Solutions. Your shortcut to performance excellence

Integrated Analytics Solutions. Your shortcut to performance excellence Integrated Analytics Solutions Your shortcut to performance excellence Integrated Analytics Solutions for Alaris System Your key to actionable infusion information Executive summary Below is a summary

More information

Safety, Life and a Just Culture. Natasha Nicol, Pharm D, FASHP Director of Global Patient Safety Affairs Cardinal Health January 29, 2016

Safety, Life and a Just Culture. Natasha Nicol, Pharm D, FASHP Director of Global Patient Safety Affairs Cardinal Health January 29, 2016 Safety, Life and a Just Culture Natasha Nicol, Pharm D, FASHP Director of Global Patient Safety Affairs Cardinal Health January 29, 2016 About me I am someone s mother, wife, daughter, granddaughter, sister,

More information

Medication Safety Learning from Ontario Coroners Cases Focus on Opioids

Medication Safety Learning from Ontario Coroners Cases Focus on Opioids Medication Safety Learning from Ontario Coroners Cases Focus on Opioids Julie Greenall ISMP Canada March 6, 2013 Institute for Safe Medication Practices Canada 2012 ISMP Canada ISMP Canada is an independent

More information

TABLE OF CONTENTS Risk of myocardial infarction with antiretroviral use 1-2

TABLE OF CONTENTS Risk of myocardial infarction with antiretroviral use 1-2 TABLE OF CONTENTS Risk of myocardial infarction with antiretroviral use 1-2 Drug induced suicidality 2-4 Pediatric medication errors 4-5 P & T formulary update 5 Risk of myocardial infarction and antiretroviral

More information

Medication Safety, Life, and

Medication Safety, Life, and Disclosure Medication Safety, Life, and a Just Culture Natasha Nicol, Pharm D, FASHP Director, Medication Safety Cardinal Health I do not have a vested interest in or affiliation with any corporate organization

More information

Utilizing Automated Adverse Event Detection

Utilizing Automated Adverse Event Detection Utilizing Automated Adverse Event Detection David C Stockwell, MD, MBA Executive Director of Improvement Science Medical Director of Patient Safety and Pediatric ICU Children s National Medical Center

More information

Reducing the risk of patient harm: A focus on opioids

Reducing the risk of patient harm: A focus on opioids Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,

More information

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations

Conflict of Interest Declaration. High Risk Medications in the Hospital Pharmacy. According to. Learning Objectives. Medication Safety Organizations Conflict of Interest Declaration High Risk Medications in the Hospital Pharmacy None to disclose Monika Gil, Pharm.D. Clinical Staff Pharmacist Rush University Medical Center Chicago, IL Learning Objectives

More information

Easy way to calculate drugs MONA ALHARBI

Easy way to calculate drugs MONA ALHARBI Easy way to calculate drugs MONA ALHARBI Objective At the end of this lecture you should be able to : Calculate dosage drugs. Calculate drip rate (drops/min). Conversion of dosages to ml/hour Calculating

More information

Intravenous Fluid and Drug Therapy

Intravenous Fluid and Drug Therapy 11 Intravenous Fluid and Drug Therapy OUTLINE Overview Direct Intravenous Injections Continuous Intravenous Injections Solution Additives Calculating IV Components as Percentages Calculating IV Flow Rates

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Postop, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

** Medication exercises ** NICU Phase II

** Medication exercises ** NICU Phase II ** Medication exercises ** NICU Phase II A) Baby A has had a bowel resection six hours ago. She weighs 3 kg. Post-op, she is quite agitated and she is on a fentanyl drip at 2 micrograms/kg/hr (#1). She

More information

Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON

Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON Key Findings from the ISMP Canada Safety Bulletins Drugs: Oversight, Safety and Supply OHA Educational Event November 20, 2015 Toronto, ON David U President & CEO ISMP Canada Ontario Critical Incident

More information

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

Opioid reduction strategies in an academic tertiary medical center

Opioid reduction strategies in an academic tertiary medical center Opioid reduction strategies in an academic tertiary medical center Terry Bosen, PharmD Medication Safety Program Director Vanderbilt University Medical Center Tennessee MME data per capita MME = Morphine

More information

PATIENT SAFETY ALERT

PATIENT SAFETY ALERT PATIENT SAFETY ALERT PROBLEM: Research in UK and elsewhere has identified a risk to patients from errors occurring during intravenous administration of potassium solutions. Potassium chloride concentrate

More information

CLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION

CLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION CLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION Sandra Kane-Gill, PharmD, MSc, FCCP, FCCM Associate Professor of Pharmacy, Critical Care Medicine and the Clinical Translational Science Institute, University

More information

Nonparenteral medications

Nonparenteral medications Nonparenteral medications Capsules and unscored tablets are rounded to the nearest whole tablet. Scored tablets are rounded to the nearest 1/2 tablet. Liquid medications are rounded to one decimal place

More information

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP

High Alert Medications in the long-term care setting. Carrie Allen PharmD, CGP, BCPS, CCHP High Alert Medications in the long-term care setting Carrie Allen PharmD, CGP, BCPS, CCHP Who does this involve? Nurses Medication aides Pharmacies/pharmacists Medical Records and Data Entry Personnel

More information

How to Set Up and Infuse Your TPN

How to Set Up and Infuse Your TPN Page 1 of 10 How to Set Up and Infuse Your TPN Important: Do not change any of the supplies listed here. Keep supplies away from children. Only your home care nurse or persons trained by Fairview Home

More information

Multiple IV Infusions: Research and Recommendations National Coalition for Infusion Therapy Safety Mar 12, 2015

Multiple IV Infusions: Research and Recommendations National Coalition for Infusion Therapy Safety Mar 12, 2015 Multiple IV Infusions: Research and Recommendations National Coalition for Infusion Therapy Safety Mar 12, 2015 Mark Fan Sonia Pinkney Andrea Cassano-Piché Overview Introduction Research findings and recommendations

More information

Davis s Drug Guide Scavenger Hunt 15 th Edition

Davis s Drug Guide Scavenger Hunt 15 th Edition Davis s Drug Guide Scavenger Hunt 15 th Edition This handout is designed to assist you in locating information in the Davis s Drug Guide. Take advantage of the many resources in this text!! Locate the

More information

Procedure for the prescribing and administration of insulin

Procedure for the prescribing and administration of insulin Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:

More information

Adverse Drug Events Steve Meisel, Pharm.D. Director of Patient Safety Fairview Health Services, Minneapolis, MN

Adverse Drug Events Steve Meisel, Pharm.D. Director of Patient Safety Fairview Health Services, Minneapolis, MN Adverse Drug Events Steve Meisel, Pharm.D. Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural to academic 50+ primary care clinics

More information

2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives:

2/9/2016. A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events. Objectives: A Multi-Disciplinary Program to Decrease the Rate of Preventable Harm from Medication Events Michigan Pharmacist Association February 28, 2016 Steven Johnson, Pharm.D. Regional Clinical Director Gay Alcenius,

More information

Error Prevention Measurement Methodology

Error Prevention Measurement Methodology Error Prevention Measurement Methodology January 1 to June 30, 2008 Version 9.0a Updated for ICD-9 CM and CPT Code Changes Effective January 1, 2008 Questions or comments can be directed to Bob Beaverson

More information

Cardiac Catheter Labs Intravenous Drug Therapy Guide

Cardiac Catheter Labs Intravenous Drug Therapy Guide Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab

More information

Prevention of Medical Errors: Concepts and Tools. Perry Johnson, PhD April 30, 2016

Prevention of Medical Errors: Concepts and Tools. Perry Johnson, PhD April 30, 2016 Prevention of Medical Errors: Concepts and Tools Perry Johnson, PhD April 30, 2016 Radiation Boom series by Walt Bogdanich At V.A. Hospital, a Rouge Cancer Unit The Radiation Boom Stereotactic Radiosurgery

More information

ISMP Update on Top Medication Safety Issues from 2018

ISMP Update on Top Medication Safety Issues from 2018 ISMP Update on Top Medication Safety Issues from 2018 Michael R. Cohen, RPh, MS, ScD (hon), DPS (hon) FASHP President, Institute for Safe Medication Practices mcohen@ismp.org 2018 Institute for Safe Medication

More information

Preventing MEDICATION ERRORS in the ICU. CHARLENE TAY Clinical Pharmacy Kuala Lumpur General Hospital

Preventing MEDICATION ERRORS in the ICU. CHARLENE TAY Clinical Pharmacy Kuala Lumpur General Hospital Preventing MEDICATION ERRORS in the ICU CHARLENE TAY Clinical Pharmacy Kuala Lumpur General Hospital 1 OUTLINE Medication Error Defined Errors in ICU Contributory Factors Types of Errors Strategies & Safe

More information

Failure Mode and Effects Analysis (FMEA) Margaret Colquhoun

Failure Mode and Effects Analysis (FMEA) Margaret Colquhoun Failure Mode and Effects Analysis (FMEA) Margaret Colquhoun Consultant, ISMP Canada Director of Pharmacy & Professional Practice, Markham Stouffville Hospital What is Failure Mode and Effects Analysis

More information

- Arterial line safety Learning from a serious untoward incident on the Intensive Care Unit.

- Arterial line safety Learning from a serious untoward incident on the Intensive Care Unit. - Arterial line safety Learning from a serious untoward incident on the Intensive Care Unit. Margi Jenkins Ex-Senior Sister Intensive care unit Royal United Hospital Bath Specialist Nurse Organ Donation

More information

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means.

Within the proportion the two outside numbers are referred to as the extremes. The two inside numbers are referred to as the means. Basic Formulas Speaker: Jana Ogden This lecture will demonstrate the expectations for performing a variety of the more complex calculations. You are expected to refer to your text and complete the designated

More information

SUPPORTING INFORMATION. for

SUPPORTING INFORMATION. for SUPPORTING INFORMATION for RAPID RESPONSE REPORT NPSA/2008/RRR06 Problems with infusions and sampling from arterial lines 28 July 2008 Background Review of Evidence of Harm NPSA National Reporting and

More information

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016

Medication Safety. Patient Safety. Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 Medication Safety Patient Safety Setting Direction Julie Simmons, Medication Safety Pharmacist January 2016 1 The patient journey Admission Ward Transfer Ward stay Discharge Medication storage and supply

More information

Reducing Adverse Drug Events: Strategies to Accelerate Improvement Webinar - Opioid Safety

Reducing Adverse Drug Events: Strategies to Accelerate Improvement Webinar - Opioid Safety This presenter has no conflicts of interest to disclose Reducing Adverse Drug Events: Strategies to Accelerate Improvement Webinar - Opioid Safety Frank Federico Vice President August 17, 2017 Objectives

More information

HIGH ALERT MEDICATIONS

HIGH ALERT MEDICATIONS PAGE: 1 of 12 1. PURPOSE This policy describes minimum standards to assure that sites, departments, and areas in Aurora Health Care that handle high risk medications have considered the risk of error associated

More information

Lisa Ramthun, RN, MSN, CPHRM AVP Risk Management

Lisa Ramthun, RN, MSN, CPHRM AVP Risk Management Lisa Ramthun, RN, MSN, CPHRM AVP Risk Management Disclosure I have no potential conflicts of interest to disclose Our systems are producing the results they were designed to produce. In other words: Benefits

More information

TRAIN FOR SUCCESS INC. PREVENTION OF MEDICAL ERRORS 2 Hr PREPARED BY MICHELLE BROOMFIELD RN

TRAIN FOR SUCCESS INC. PREVENTION OF MEDICAL ERRORS 2 Hr PREPARED BY MICHELLE BROOMFIELD RN PREPARED BY MICHELLE BROOMFIELD RN 1 Purpose This course was designed to be provided through didactic training. The course will be available within the classroom as well as online. The purpose of this

More information

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies

Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Improving Inpatient Diabetes Care: Focus on Safe Use of Anti-diabetic Therapies Leigh Briscoe-Dwyer, PharmD, BCPS, FASHP Chief Pharmacy and Medication Safety Officer North Shore Long Island Jewish Health

More information

Technician Tutorial: Dispensing Insulin and Other Injectable Meds

Technician Tutorial: Dispensing Insulin and Other Injectable Meds (Page 1 of 6) Technician Tutorial: Dispensing Insulin and Other Injectable Meds Insulin is a hormone secreted by the pancreas. It helps the body use glucose as an energy source. Insulin acts like a key

More information

Preventing Adverse Drug Events and Harm

Preventing Adverse Drug Events and Harm Preventing Adverse Drug Events and Harm Frank Federico, RPh, IHI Executive Director Steve Meisel, Pharm.D., IHI Faculty February 14,2012 12:00-1:00pm ET Beth O Donnell, MPH Beth O Donnell, MPH, Institute

More information

Targeted Medication Safety Best Practices for Hospitals

Targeted Medication Safety Best Practices for Hospitals 2018-2019 Targeted Medication Safety Best Practices for Hospitals The purpose of the Targeted Medication Safety Best Practices for Hospitals is to identify, inspire, and mobilize widespread, national adoption

More information

CONSOLE, COACH, OR PUNISH?

CONSOLE, COACH, OR PUNISH? CONSOLE, COACH, OR PUNISH? DAVID MARX MARCH 8, 2017 2017 Michigan Patient Safety and Quality Symposium THE TOPIC THE PROBLEM US YOU, ME, THAT PERSON SITTING NEXT TO YOU We are inherently self-serving,

More information

Improving Patient Safety and Compliance

Improving Patient Safety and Compliance Improving Patient Safety and Compliance Module 4 Includes Recommended Procedures Table of Contents Section A... 1 A.1 Intrathecal (IT) Doses... 1 Section B... 1 B.1 Vinca Alkaloids... 1 Section C... 2

More information

Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN

Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN Disclosure Information Intravenous Therapy and Parenteral Nutrition Administration: Nursing In- Focus Jo Kuehn, RN, MSN, CPHQ and Jenell Westhoven, RN,

More information

Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters

Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters Reducing Intermittent Infusion Syringe Pump Errors via Weight-Based Safety Parameters Alison Bloomquist and Laura Seiberlich Abstract Historically, smart infusion pumps with dose error reduction software

More information

Rapid Response Report 2

Rapid Response Report 2 Rapid Response Report 2 Additional information to support the NPSA Rapid Response issued on 3 September 2007 Risk of confusion between non-lipid and lipid formulations of injectable amphotericin The NPSA

More information

Failure Modes Effects Analysis of Morphine Prescribing

Failure Modes Effects Analysis of Morphine Prescribing Failure Modes Effects Analysis of Morphine Prescribing Hilary Writer MD FRCPC Elaine Wong BScPhm CPSI Patient Safety and Quality Improvement Forum,14 April 2010 Outline Rationale Medication Incidents with

More information

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives

Faculty. Disclosures. Prescribing. A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy. Learning Objectives A Multidisciplinary Approach to Preventing Medication Errors Associated with Insulin Therapy Faculty Matthew Grissinger, RPh, FISMP, FASCP Director, Error Reporting Programs Institute for Safe Medication

More information

Type I Type II Insulin Resistance

Type I Type II Insulin Resistance Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100

More information

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults

ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults 2017 ISMP Guidelines for Optimizing Safe Subcutaneous Insulin Use in Adults Table of Contents Introduction 3 Risk Associated with Subcutaneous Insulin Use in Adults 5 Risk Associated with Prescribing Subcutaneous

More information

Anticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010

Anticoagulation therapy : improving processes. Hilary Merrett and Fiona Gale, CHKS 18 th October 2010 Anticoagulation therapy : improving processes using risk management tools Hilary Merrett and Fiona Gale, CHKS 18 th October 2010 Risk management tools and anticoagulation therapy The applicable processes

More information

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE

Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating Service PROCEDURE UNIVERSITY OF MICHIGAN HOSPITALS AND HEALTH CENTERS UMHHC-HCS: 253.054 First Approved Date: 3/2010 Home Care Services HomeMed MedEQUIP Michigan Visiting Care Michigan Visiting Nurses Wheelchair Seating

More information

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients)

Introduction. Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Guidelines for patient involvement in the administration of insulin under supervision in hospital (Adult patients) Introduction This guideline is designed to provide a framework for patients to administer

More information

Ratios and Proportions. Calculations for Pharmacy Technicians 9/21/2017. Presented by: Antonia Kraljevic PGY2 Pharmacy Practice Resident

Ratios and Proportions. Calculations for Pharmacy Technicians 9/21/2017. Presented by: Antonia Kraljevic PGY2 Pharmacy Practice Resident Calculations for Pharmacy Technicians Presented by: Antonia Kraljevic PGY2 Pharmacy Practice Resident The speaker has no actual or potential conflict of interest in relation to this presentation. Pharmacy

More information

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service

Suicide Prevention: From a Pharmacist s Perspective. Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service Suicide Prevention: From a Pharmacist s Perspective Daina L. Wells, Pharm.D., BCPS, BCPP VA PBM Academic Detailing Service CPE Information and Disclosures Daina L. Wells declare(s) no conflicts of interest,

More information

Are We Making Smart Pumps Smarter?

Are We Making Smart Pumps Smarter? Butler University Digital Commons @ Butler University Undergraduate Honors Thesis Collection Undergraduate Scholarship 2018 Are We Making Smart Pumps Smarter? Brittany Schaefer Butler University Follow

More information

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no

Naloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any

More information

Risk Management in Parenteral Nutrition. J. Boullata

Risk Management in Parenteral Nutrition. J. Boullata Risk Management in Parenteral Nutrition J. Boullata Objectives Upon completion of this session, the participant will be able to: Describe safety issues with parenteral nutrition (PN) Present the PN-use

More information

D DAVID PUBLISHING. 1. Introduction. Shannon Inglet 1, Michael Curcio 2 and Lada Radetic 3

D DAVID PUBLISHING. 1. Introduction. Shannon Inglet 1, Michael Curcio 2 and Lada Radetic 3 Journal of Pharmacy and Pharmacology 6 (2018) 197-201 doi: 10.17265/2328-2150/2018.03.001 D DAVID PUBLISHING Evaluation of Opioid Reversal with Naloxone before and after Implementation of a Computerized

More information

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211

Math for Meds. College of Southern Nevada. Practice Problems. Nursing 211 Math for Meds College of Southern Nevada Nursing 211 Name: Date: Directions: 1. Solve the dosage calculation problems utilizing the method of your choice. 2. Show your work! 3.Divide math out to the thousandth

More information

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes

Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Applying STPA to the Artificial Pancreas for People with Type 1 Diabetes Lane Desborough Product Strategist Medtronic Diabetes Northridge, California Type 1 Diabetes Artificial Pancreas Challenges Applying

More information

Heparin Drip. Ordering

Heparin Drip. Ordering Heparin Drip Ordering Nurse entering of Heparin drip orders for physicians should only occur in situations when it is not feasible for the physician to enter orders directly Select the Heparin IV Drip

More information

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL

NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE PROTOCOLS EPTIFIBATIDE (INTEGRILIN) PROTOCOL NURSING DEPARTMENT CRITICAL CARE POLICY MANUAL CRITICAL CARE S EPTIFIBATIDE (INTEGRILIN) I. PURPOSE: A. Integrilin (Eptifibatide) is a specific and potent inhibitor of the platelet receptor glycoprotein

More information

MICAFUNGIN MIXING

MICAFUNGIN MIXING 1 1-800-862-2731 MICAFUNGIN MIXING Drug Name: MICAFUNGIN Volume and Rate: over 1 hour Schedule: KEY POINTS: FLUSHING: Saline Micafungin Saline Heparin 1. Always wash your hands with an antibacterial soap

More information

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc.

SAFE INJECTION PRACTICES. Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. SAFE INJECTION PRACTICES Barbara J Connell MS,MT(ASCP)SH VP Clinical Services Medline Industries, Inc. DISCLOSURES»Employee of Medline Industries, Inc.»Opinions expressed are my own and not necessarily

More information

Sample Drug Incident Report Form

Sample Drug Incident Report Form Sample Drug Incident Report Form Drug incident - patient safety report 1. As per Standard 1.9 of the Standards of Practice for Pharmacists and Pharmacy Technicians, each pharmacist and pharmacy technician

More information

Difficult Situations in the NICU. Esther Chon, PhD, EdM Miller Children s Hospital NICU Small Baby Unit Training July, 2016

Difficult Situations in the NICU. Esther Chon, PhD, EdM Miller Children s Hospital NICU Small Baby Unit Training July, 2016 Difficult Situations in the NICU Esther Chon, PhD, EdM Miller Children s Hospital NICU Small Baby Unit Training July, 2016 TOPICS Compassion Fatigue, Burnout and PTSD Dealing with Death and Loss Moral

More information

Quality Improvement Impact Activity for Insulin Pen Safety. Kosair Children s Hospital Louisville, Kentucky

Quality Improvement Impact Activity for Insulin Pen Safety. Kosair Children s Hospital Louisville, Kentucky Quality Improvement Impact Activity for Insulin Pen Safety Kosair Children s Hospital Louisville, Kentucky Tristan Murray, Pharm.D., BCPS, Team Leader June 2015 Team Members Tristan Murray, Pharm.D., BCPS

More information

The Human as Hero and Hazard. Human Factors

The Human as Hero and Hazard. Human Factors Provided in association with The Human as Hero and Hazard Human Factors Trevor Dale FRAeS Good people trying their best Human Factors What do people do that makes your working day easier or more challenging?

More information

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45

Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 Fairview Southdale Hospital Total Points: 50 RN/LPN Medication Assessment Passing: 45 1. Your diabetic patient is to be started on an insulin drip at 8 units/hour. The insulin is supplied: 100 units in

More information

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative

Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Naloxone Standardized Procedures Illinois Departments of DFPR, DPH & DHS Opioid Antagonist Initiative Background: In September 2015, Illinois passed a new law, PA99-0480, expanding access to the opioid

More information

DRUG ORDERING & DISPENSING:

DRUG ORDERING & DISPENSING: STUDY DRUG: List the study drugs that will be used at your site based on your hospital formulary 1. Insulin Humulin R 2. Insulin Humalog 3. Insulin Lantus DRUG SUPPLY & STORAGE: Since study drugs are not

More information

*Note - If associate is unsuccessful in their attempt to complete the dosage calculation test

*Note - If associate is unsuccessful in their attempt to complete the dosage calculation test Competency Statement: Demonstrates ability to use basic mathematic concepts related to the correct administration of medications. Instructional Strategies: Review of basic math concepts, completion of

More information

NICU Glucose Management AKA The Insulin Protocol

NICU Glucose Management AKA The Insulin Protocol NICU Glucose Management AKA The Insulin Protocol Laurie Love, APRN, CNP, CPS Jennifer Rivera, APRN, CNS Background Insulin causes about 10-12 cases of hypoglycemia per year in the NICUs at Children s,

More information

MedXellence Medical Incident Analysis: Group Exercise. Guidance Materials for the Patient Safety Video Presentation

MedXellence Medical Incident Analysis: Group Exercise. Guidance Materials for the Patient Safety Video Presentation MedXellence Medical Incident Analysis: Group Exercise Guidance Materials for the Patient Safety Video Presentation In this exercise you will observe a clinical/administrative sequence of events that that

More information

POSITION STATEMENT. Safer design of vaccines packaging and labelling

POSITION STATEMENT. Safer design of vaccines packaging and labelling 2015 POSITION STATEMENT Safer design of vaccines packaging and labelling POSITION STATEMENT The International Medication Safety Network recommends the following steps as part of a comprehensive, worldwide

More information

Pain Module. Top Ten Pain Safety Tips

Pain Module. Top Ten Pain Safety Tips Pain Module Top Ten Pain Safety Tips # 1 Monitor Your Patient s Level of Consciousness and Respiratory Status Do not depend on alarms to save your patient s life. You must perform your own assessments

More information

Pharmacy Instructions for Preparation

Pharmacy Instructions for Preparation MARQIBO (vincristine sulfate LIPOSOME injection) Pharmacy Instructions for Preparation Important Information for Preparation 1 The instructions for the constitution of MARQIBO are provided in each kit.

More information

Pharmacy Plan Guidance

Pharmacy Plan Guidance Pharmacy Plan Guidance The pharmacy plan is a tool used during the site readiness process to develop and document the site-specific procedures for study drug ordering, labeling and dispensing for the SHINE

More information

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.

The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse

More information

Know the 10 Signs: Early Detection Matters

Know the 10 Signs: Early Detection Matters Know the 10 Signs: Early Detection Matters 1 Importance of Early Detection If we could have had a correct diagnosis even two years earlier, it would have given us more time to plan, to do the things that

More information

nisterine Medications

nisterine Medications nisterine Medications Pharmacology for Health Careers sixth edition Donna F. Gauwitz, R.N., M.S. Nursing Consultant Former Senior Teaching Specialist School of Nursing University of Minnesota Minneapolis,

More information

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph..

Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Sterile Product Preparation for Non-Pharmacy Personnel Dennis Sinclair, R.Ph.. Objectives Describe the importance of accuracy and use of proper aseptic technique when preparing IV medications. Identify

More information

Injections Without Infections:

Injections Without Infections: Injections Without Infections: Basic Patient Safety Joseph Perz, DrPH Team Leader, Ambulatory and Long-Term Care Prevention and Response Branch Division of Healthcare Quality Promotion Centers for Disease

More information